Form 4: Elanco Animal Health Inc. Director Acquires Shares in Open Market Transaction

Director Michael J. Harrington purchased 3,100 shares of Elanco Animal Health Inc. common stock at a price of $16.2883 per share on March 8, 2024.

Summary

• On March 8, 2024, Michael J. Harrington, a director of Elanco Animal Health Inc., acquired 3,100 shares of common stock.
• The purchase price was $16.2883 per share.
• Following the transaction, Harrington directly owns 77,594 shares of Elanco Animal Health Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director buying shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's financial health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Directors' transactions are routinely monitored as indicators of company health and management confidence. This purchase aligns with standard practices of corporate governance and insider trading regulations.

Comparison to Industry Standards

• Director stock purchases are common across publicly traded companies.
• The significance of this purchase would be better understood by comparing it to the director's past trading activity and the trading activity of other insiders at Elanco Animal Health Inc.
• Benchmarking against similar transactions in peer companies within the animal health industry could provide further context.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates